3 studies found for:    18266997 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Enrolling by invitation Liver Function Measured by HepQuant-SHUNT in the Prediction of Outcomes in Patients With Heart Disease
Conditions: Liver Disease;   Cardiovascular Disease
Intervention: Drug: Cholate testing
2 Recruiting Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis
Condition: Hepatitis C
Interventions: Drug: Simeprivir (SMV);   Drug: Sofosbuvir (SOF);   Drug: Ribavirin (RBV)
3 Active, not recruiting Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal Circulation
Conditions: Hepatitis C, Chronic;   Non-Alcoholic Fatty Liver Disease
Intervention: Device: Cholate-24-13C (IND 65121) & Cholate-2,2,4,4-d4 (IND 65123)

Indicates status has not been verified in more than two years